Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1/CTLA-4”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07397442
What this trial is testing

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III
Beijing Friendship Hospital 19
Early research (Phase 1)Study completedNCT03507699
What this trial is testing

Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms MalignantLiver Metastases
Sheba Medical Center 19
Early research (Phase 1)Temporarily pausedNCT04840589
What this trial is testing

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Platinum-Resistant Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT04868708
What this trial is testing

AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Akeso 50
Early research (Phase 1)UnknownNCT03527251
What this trial is testing

Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Sun Yat-sen University 10
Not applicableLooking for participantsNCT07354971
What this trial is testing

IMMUNO-FIT Observational Study

Who this might be right for
NeoplasmsImmunotherapyPhysical Fitness+2 more
University Hospital Southampton NHS Foundation Trust 67
Testing effectiveness (Phase 2)Looking for participantsNCT06367075
What this trial is testing

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft-tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Testing effectiveness (Phase 2)Looking for participantsNCT06769971
What this trial is testing

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Who this might be right for
Small Cell Lung Cancer
Sichuan University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Looking for participantsNCT03198052
What this trial is testing

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers

Who this might be right for
Lung CancerCancerImmunotherapy+1 more
Second Affiliated Hospital of Guangzhou Medical University 30
Early research (Phase 1)Not Yet RecruitingNCT07476326
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Who this might be right for
Melanoma
Biocon Biologics UK PLC 120
Early research (Phase 1)Study completedNCT03293784
What this trial is testing

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma

Who this might be right for
Melanoma
Institut Claudius Regaud 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07533305
What this trial is testing

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
QL1706ESCCFirst-line Therapy
The First Affiliated Hospital of Henan University of Science and Technology 50
Testing effectiveness (Phase 2)Looking for participantsNCT06941857
What this trial is testing

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableLooking for participantsNCT05139706
What this trial is testing

Montreal Immune-Related Adverse Events (MIRAE) Study

Who this might be right for
CancerImmune System DisorderInflammatory Reaction+1 more
Sir Mortimer B. Davis - Jewish General Hospital 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03894215
What this trial is testing

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Who this might be right for
Cervical Cancer
Agenus Inc. 211
Testing effectiveness (Phase 2)Ended earlyNCT03116529
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Maryland, Baltimore 22
Testing effectiveness (Phase 2)Looking for participantsNCT06532617
What this trial is testing

Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Not applicableEnrolling By InvitationNCT06714084
What this trial is testing

CNCMT：a Multi-center, Prospective, Single-arm Study

Who this might be right for
Locally Advanced Cervical CancerPD1CTLA4
Hubei Cancer Hospital 20
Load More Results